Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Merck KGaA Acquires Cell Culture Media Specialist Biochrom AG

Published: Friday, August 24, 2012
Last Updated: Thursday, August 23, 2012
Bookmark and Share
Acquisition rounds out EMD Millipore’s portfolio of media and buffers used in biopharmaceutical production.

EMD Millipore has announced that it has entered into definitive agreements to acquire Biochrom AG located in Berlin, Germany.

The company, with approximately 60 employees and sales of approximately € 13 million in 2011, specializes in the production and marketing of cell-culture media and buffer solutions.

The parties agreed not to disclose the purchase price. The acquisition is subject to customary closing conditions such as the approval of the respective antitrust authority.

Closing of the transaction is expected in the fourth quarter of 2012.

The acquisition will strengthen EMD Millipore’s Process Solutions business unit, which provides products, services and solutions that simplify production complexity for pharmaceutical and biopharmaceutical manufacturers.

Biochrom’s cell-culture media products are highly complementary and innovative, adding liquid cell-culture media and buffers including serum-free products and disposable packaging solutions to the existing portfolio.

“With Biochrom we have a great opportunity to deliver an expanded portfolio of cell-culture media products to our global customers and address a growing demand for ready-to-use liquid solutions that drive safety and efficiency in the development and manufacture of clinical and commercial drug materials,” said Robert Yates, head of the EMD Millipore division.

Dr. Bernd Frenzel, CEO of Biochrom AG, said: “EMD Millipore is the ideal partner for Biochrom. With EMD Millipore we will be able to leverage their industry relationships and global footprint to reach more customers and offer a more comprehensive portfolio of media and buffers”.

It is planned to maintain Biochrom’s operations in Berlin. Biochrom’s activities will be part of EMD Millipore’s Process Solutions business unit.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Enhanced Analysis of Extracellular Vesicles with Imaging Flow Cytometry
Once thought of as cellular debris, extracellular vesicles are now recognized as key messengers that mitigate cell-cell communication.
Monday, May 11, 2015
EMD Millipore and PharmaCell Announces Collaboration
Collaboration to evaluate EMD Millipore’s Mobius® bioreactor platform for expansion of HepaRG® cells.
Friday, May 24, 2013
EMD Millipore and Sistemic Collaborate
Companies jointly developing kits for quality control of in vitro stem cell cultures.
Friday, November 02, 2012
EMD Millipore Wins R&D Magazine 100 Award
Samplicity® Filtration System recognized as one of the 100 most technologically significant products introduced into marketplace.
Monday, July 09, 2012
EMD Millipore Acquires Amnis Corporation
EMD Millipore announces it has agreed to acquire Amnis Corporation, manufacturers of high speed cell imaging instrumentation.
Monday, September 05, 2011
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!